Medical - Care Facilities
Compare Stocks
4 / 10Stock Comparison
EHAB vs ACHC vs SEM vs SGRY
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
EHAB vs ACHC vs SEM vs SGRY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $706M | $2.25B | $2.04B | $1.87B |
| Revenue (TTM) | $1.06B | $3.37B | $5.52B | $3.34B |
| Net Income (TTM) | $-3M | $-1.11B | $134M | $-76M |
| Gross Margin | 34.5% | 56.2% | 10.6% | 22.8% |
| Operating Margin | 7.2% | 11.7% | 5.8% | 11.8% |
| Forward P/E | 22.8x | 16.4x | 13.1x | 38.0x |
| Total Debt | $500M | $2.65B | $3.70B | $4.02B |
| Cash & Equiv. | $44M | $133M | $27M | $240M |
EHAB vs ACHC vs SEM vs SGRY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 22 | May 26 | Return |
|---|---|---|---|
| Enhabit, Inc. (EHAB) | 100 | 60.0 | -40.0% |
| Acadia Healthcare C… (ACHC) | 100 | 36.2 | -63.8% |
| Select Medical Hold… (SEM) | 100 | 129.2 | +29.2% |
| Surgery Partners, I… (SGRY) | 100 | 49.5 | -50.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EHAB vs ACHC vs SEM vs SGRY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EHAB is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 0 yrs, beta 0.44
- Lower volatility, beta 0.44, Low D/E 88.6%, current ratio 1.63x
- Beta 0.44, current ratio 1.63x
- Beta 0.44 vs SGRY's 1.04, lower leverage
ACHC lags the leaders in this set but could rank higher in a more targeted comparison.
SEM carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 158.5% 10Y total return vs EHAB's -44.9%
- Lower P/E (13.1x vs 38.0x)
- 2.4% margin vs ACHC's -32.8%
- 1.5% yield; the other 3 pay no meaningful dividend
SGRY is the clearest fit if your priority is growth exposure.
- Rev growth 6.2%, EPS growth 54.1%, 3Y rev CAGR 9.2%
- 6.2% revenue growth vs EHAB's 2.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.2% revenue growth vs EHAB's 2.4% | |
| Value | Lower P/E (13.1x vs 38.0x) | |
| Quality / Margins | 2.4% margin vs ACHC's -32.8% | |
| Stability / Safety | Beta 0.44 vs SGRY's 1.04, lower leverage | |
| Dividends | 1.5% yield; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +68.0% vs SGRY's -38.2% | |
| Efficiency (ROA) | 2.3% ROA vs ACHC's -18.6%, ROIC 4.8% vs 5.9% |
EHAB vs ACHC vs SEM vs SGRY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EHAB vs ACHC vs SEM vs SGRY — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SEM leads in 2 of 6 categories
EHAB leads 2 • ACHC leads 1 • SGRY leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ACHC and SGRY each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SEM is the larger business by revenue, generating $5.5B annually — 5.2x EHAB's $1.1B. SEM is the more profitable business, keeping 2.4% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, ACHC holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $3.4B | $5.5B | $3.3B |
| EBITDAEarnings before interest/tax | $98M | $588M | $465M | $572M |
| Net IncomeAfter-tax profit | -$3M | -$1.1B | $134M | -$76M |
| Free Cash FlowCash after capex | $81M | -$215M | $117M | $208M |
| Gross MarginGross profit ÷ Revenue | +34.5% | +56.2% | +10.6% | +22.8% |
| Operating MarginEBIT ÷ Revenue | +7.2% | +11.7% | +5.8% | +11.8% |
| Net MarginNet income ÷ Revenue | -0.3% | -32.8% | +2.4% | -2.3% |
| FCF MarginFCF ÷ Revenue | +7.6% | -6.4% | +2.1% | +6.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.9% | +7.6% | +5.0% | +4.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.9% | -49.8% | -18.2% | +6.7% |
Valuation Metrics
SEM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than EHAB's 13.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $706M | $2.3B | $2.0B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $4.8B | $5.7B | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | -152.10x | -2.01x | 13.93x | -23.46x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.84x | 16.42x | 13.06x | 37.99x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 13.47x | 8.27x | 12.04x | 10.00x |
| Price / SalesMarket cap ÷ Revenue | 0.67x | 0.68x | 0.37x | 0.57x |
| Price / BookPrice ÷ Book value/share | 1.24x | 1.04x | 1.00x | 0.52x |
| Price / FCFMarket cap ÷ FCF | 10.73x | — | 5.33x | 9.57x |
Profitability & Efficiency
EHAB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SEM delivers a 6.6% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-41 for ACHC. EHAB carries lower financial leverage with a 0.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEM's 1.82x. On the Piotroski fundamental quality scale (0–9), EHAB scores 6/9 vs SGRY's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -0.6% | -40.9% | +6.6% | -2.2% |
| ROA (TTM)Return on assets | -0.3% | -18.6% | +2.3% | -0.9% |
| ROICReturn on invested capital | +4.5% | +5.9% | +4.8% | +4.1% |
| ROCEReturn on capital employed | +6.0% | +7.5% | +7.0% | +5.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.89x | 1.24x | 1.82x | 1.14x |
| Net DebtTotal debt minus cash | $456M | $2.5B | $3.7B | $3.8B |
| Cash & Equiv.Liquid assets | $44M | $133M | $27M | $240M |
| Total DebtShort + long-term debt | $500M | $2.7B | $3.7B | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.83x | -5.99x | 4.41x | 1.35x |
Total Returns (Dividends Reinvested)
SEM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SEM five years ago would be worth $8,886 today (with dividends reinvested), compared to $2,773 for SGRY. Over the past 12 months, EHAB leads with a +68.0% total return vs SGRY's -38.2%. The 3-year compound annual growth rate (CAGR) favors SEM at 2.4% vs ACHC's -29.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +51.6% | +71.2% | +11.4% | -6.2% |
| 1-Year ReturnPast 12 months | +68.0% | +1.2% | +11.1% | -38.2% |
| 3-Year ReturnCumulative with dividends | +2.1% | -64.5% | +7.4% | -59.2% |
| 5-Year ReturnCumulative with dividends | -44.9% | -61.8% | -11.1% | -72.3% |
| 10-Year ReturnCumulative with dividends | -44.9% | -58.5% | +158.5% | -0.6% |
| CAGR (3Y)Annualised 3-year return | +0.7% | -29.2% | +2.4% | -25.8% |
Risk & Volatility
EHAB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EHAB is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than SGRY's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EHAB currently trades 96.9% from its 52-week high vs SGRY's 59.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.84x | 0.46x | 1.04x |
| 52-Week HighHighest price in past year | $14.22 | $30.20 | $16.99 | $24.18 |
| 52-Week LowLowest price in past year | $6.47 | $11.43 | $11.65 | $11.41 |
| % of 52W HighCurrent price vs 52-week peak | +96.9% | +81.0% | +96.8% | +59.2% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 46.2 | 60.9 | 63.3 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 3.1M | 2.1M | 1.5M |
Analyst Outlook
ACHC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: EHAB as "Hold", ACHC as "Buy", SEM as "Hold", SGRY as "Buy". Consensus price targets imply 30.0% upside for SGRY (target: $19) vs -3.9% for ACHC (target: $24). SEM is the only dividend payer here at 1.55% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $13.53 | $23.50 | $18.00 | $18.60 |
| # AnalystsCovering analysts | 11 | 25 | 13 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.5% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — | $0.25 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.2% | +4.9% | 0.0% |
SEM leads in 2 of 6 categories (Valuation Metrics, Total Returns). EHAB leads in 2 (Profitability & Efficiency, Risk & Volatility). 1 tied.
EHAB vs ACHC vs SEM vs SGRY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EHAB or ACHC or SEM or SGRY a better buy right now?
For growth investors, Surgery Partners, Inc.
(SGRY) is the stronger pick with 6. 2% revenue growth year-over-year, versus 2. 4% for Enhabit, Inc. (EHAB). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate Acadia Healthcare Company, Inc. (ACHC) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EHAB or ACHC or SEM or SGRY?
On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13.
1x.
03Which is the better long-term investment — EHAB or ACHC or SEM or SGRY?
Over the past 5 years, Select Medical Holdings Corporation (SEM) delivered a total return of -11.
1%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: SEM returned +158. 5% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EHAB or ACHC or SEM or SGRY?
By beta (market sensitivity over 5 years), Enhabit, Inc.
(EHAB) is the lower-risk stock at 0. 44β versus Surgery Partners, Inc. 's 1. 04β — meaning SGRY is approximately 135% more volatile than EHAB relative to the S&P 500. On balance sheet safety, Enhabit, Inc. (EHAB) carries a lower debt/equity ratio of 89% versus 182% for Select Medical Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — EHAB or ACHC or SEM or SGRY?
By revenue growth (latest reported year), Surgery Partners, Inc.
(SGRY) is pulling ahead at 6. 2% versus 2. 4% for Enhabit, Inc. (EHAB). On earnings-per-share growth, the picture is similar: Enhabit, Inc. grew EPS 97. 1% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, SGRY leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EHAB or ACHC or SEM or SGRY?
Select Medical Holdings Corporation (SEM) is the more profitable company, earning 2.
7% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus 6. 0% for EHAB. At the gross margin level — before operating expenses — EHAB leads at 46. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EHAB or ACHC or SEM or SGRY more undervalued right now?
On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.
1x forward P/E versus 38. 0x for Surgery Partners, Inc. — 24. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SGRY: 30. 0% to $18. 60.
08Which pays a better dividend — EHAB or ACHC or SEM or SGRY?
In this comparison, SEM (1.
5% yield) pays a dividend. EHAB, ACHC, SGRY do not pay a meaningful dividend and should not be held primarily for income.
09Is EHAB or ACHC or SEM or SGRY better for a retirement portfolio?
For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, SGRY: -0. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EHAB and ACHC and SEM and SGRY?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EHAB is a small-cap quality compounder stock; ACHC is a small-cap quality compounder stock; SEM is a small-cap deep-value stock; SGRY is a small-cap quality compounder stock. SEM pays a dividend while EHAB, ACHC, SGRY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.